← All trials
NCT00609375
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2006
- Primary completion
- Dec 1, 2007
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Pontificia Universidad JaverianaLead sponsor
- Pontificia Universidad JaverianaOverall official - principal investigator
- Pontificia Universidad JaverianaStudy chair
- Universidad El Bosque, BogotáCollaborator
- Hospital Santa Clara, BogotaCollaborator
- Hospital san Juan de Dios, AntioquiaCollaborator
- Universidad Nacional de ColombiaCollaborator
- Universidad San JorgeCollaborator
- Asociacion Colombiana de InfectologiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.